Naimeh Mesri Alamdari

10PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsAutoimmunityCardiology (incl. cardiovascular diseases)Computational statistics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 18, 2026
Nutraceuticals for Preventing and Managing Cancer Chemotherapy-Induced Cardiotoxicity: An Updated Comprehensive Review.

|Dec 03, 2025
The Long-Term Effects of Postoperative Radiotherapy in Acromegaly: Results From a Single-Center Acromegaly Registry in Iran.

Farzad Najafipour, Javad Jafarpour, Amir Bahrami

|Mar 05, 2025
The effects of empagliflozin in patients with type 1 diabetes: Results of a 12-week, double-blind, randomized, placebo-controlled clinical trial.

Mostafa Najafipour, Farzad Najafipour, Alireza Ostadrahimi

|Oct 31, 2024
Assessment of the anti-inflammatory and anti-glycemic properties of Royal Jelly and Tocotrienol-rich fraction in an experimental study: Does irisin mediate these effects?

Naimeh Mesri Alamdari, Pardis Irandoost, Neda Roshanravan

|Sep 18, 2024
Risk factors for atherosclerotic cardiovascular disease (ASCVD) in healthcare professionals of Azar Cohort Study: A cross-sectional Study.

Neda Roshanravan, Helda Tutunchi, Rezayat Parvizi

|Jun 01, 2024
Disparity of gene expression in coronary artery disease: insights from MEIS1, HIRA, and Myocardin.

Elnaz Javanshir, Zahra Javadpour Ebrahimi, Seyedeh Tarlan Mirzohreh

Pageof 2

Frequent Collaborators

6 joint publications

Neda Roshanravan

5 joint publications

Samad Ghaffari

3 joint publications

Erfan Banisefid

2 joint publications

Farzad Najafipour